Endometrial Cancer Market
Endometrial Cancer Market - Global Industry Assessment & Forecast
#
Pages:
198
Base Year:
2023
Jun - 2024
Format:
Report Code:
VMR-2522
Segments Covered
By
Type of Cancer Endometrial Carcinoma, Uterine Sarcomas, Others
-
By
Type of Therapy Immunotherapy, Radiation Therapy, Chemotherapy, Others
-
By
Diagnosis Method Biopsy, CT Scan Hysteroscopy, Pelvic Ultrasound, Other Diagnosis Methods
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 28.2 Billion |
 Revenue 2032:
|
USD 46.86 Billion |
 Revenue CAGR
(2024 - 2032): |
5.8% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Endometrial Cancer Market Segment Analysis
- Endometrial Cancer Type of Cancer Outlook (Revenue, USD Million, 2018 - 2030)
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- Endometrial Cancer Type of Therapy Outlook (Revenue, USD Million, 2018 - 2030)
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- Endometrial Cancer Diagnosis Method Outlook (Revenue, USD Million, 2018 - 2030)
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
-
North America Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
-
North America Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- U.S.
- U.S. Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- U.S. Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- U.S. Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- U.S. Endometrial Cancer Market, by Type of Cancer
- Canada
- Canada Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- Canada Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- Canada Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- Canada Endometrial Cancer Market, by Type of Cancer
-
Mexico
- Mexico Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- Mexico Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- Mexico Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- Mexico Endometrial Cancer Market, by Type of Cancer
-
North America Endometrial Cancer Market, by Type of Cancer
- Europe
-
Europe Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
-
Europe Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
-
Europe Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- U. K.
- U.K. Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- U.K. Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- U.K. Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- U.K. Endometrial Cancer Market, by Type of Cancer
- France
- France Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- France Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- France Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- France Endometrial Cancer Market, by Type of Cancer
-
Germany
- Germany Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- Germany Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- Germany Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- Germany Endometrial Cancer Market, by Type of Cancer
-
Italy
- Italy Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- Italy Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- Italy Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- Italy Endometrial Cancer Market, by Type of Cancer
-
Spain
- Spain Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- Spain Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- Spain Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- Spain Endometrial Cancer Market, by Type of Cancer
-
Rest of Europe
- Rest of Europe Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- Rest of Europe Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- Rest of Europe Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- Rest of Europe Endometrial Cancer Market, by Type of Cancer
-
Europe Endometrial Cancer Market, by Type of Cancer
- Asia Pacific
-
Asia Pacific Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
-
Asia Pacific Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
-
Asia Pacific Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- China
- China Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- China Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- China Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- China Endometrial Cancer Market, by Type of Cancer
- Japan
- Japan Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- Japan Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- Japan Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- Japan Endometrial Cancer Market, by Type of Cancer
-
Germany
- Germany Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- Germany Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- Germany Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- Germany Endometrial Cancer Market, by Type of Cancer
-
India
- India Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- India Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- India Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- India Endometrial Cancer Market, by Type of Cancer
-
South Korea
- South Korea Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- South Korea Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- South Korea Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- South Korea Endometrial Cancer Market, by Type of Cancer
-
South East Asia
- South East Asia Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- South East Asia Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- South East Asia Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- South East Asia Endometrial Cancer Market, by Type of Cancer
-
Rest of Asia Pacific
- Rest of Asia Pacific Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- Rest of Asia Pacific Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- Rest of Asia Pacific Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- Rest of Asia Pacific Endometrial Cancer Market, by Type of Cancer
-
Asia Pacific Endometrial Cancer Market, by Type of Cancer
- Latin America
-
Latin America Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
-
Latin America Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
-
Latin America Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- Brazil
- Brazil Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- Brazil Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- Brazil Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- Brazil Endometrial Cancer Market, by Type of Cancer
- Argentina
- Argentina Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- Argentina Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- Argentina Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- Argentina Endometrial Cancer Market, by Type of Cancer
-
Rest of Latin America
- Rest of Latin America Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- Rest of Latin America Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- Rest of Latin America Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- Rest of Latin America Endometrial Cancer Market, by Type of Cancer
-
Latin America Endometrial Cancer Market, by Type of Cancer
- Middle East & Africa
-
Middle East & Africa Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
-
Middle East & Africa Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
-
Middle East & Africa Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- GCC Countries
- GCC Countries Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- GCC Countries Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- GCC Countries Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- GCC Countries Endometrial Cancer Market, by Type of Cancer
- South Africa
- South Africa Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- South Africa Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- South Africa Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- South Africa Endometrial Cancer Market, by Type of Cancer
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Endometrial Cancer Market, by Type of Cancer
- Endometrial Carcinoma
- Uterine Sarcomas
- Others
- Rest of Middle East & Africa Endometrial Cancer Market, by Type of Therapy
- Immunotherapy
- Radiation Therapy
- Chemotherapy
- Others
- Rest of Middle East & Africa Endometrial Cancer Market, by Diagnosis Method
- Biopsy
- CT Scan Hysteroscopy
- Pelvic Ultrasound
- Other Diagnosis Methods
- Rest of Middle East & Africa Endometrial Cancer Market, by Type of Cancer
-
Middle East & Africa Endometrial Cancer Market, by Type of Cancer
- North America
FAQ
Frequently Asked Question
What is the global demand for Endometrial Cancer in terms of revenue?
-
The global Endometrial Cancer valued at USD 28.2 Billion in 2023 and is expected to reach USD 46.86 Billion in 2032 growing at a CAGR of 5.8%.
Which are the prominent players in the market?
-
The prominent players in the market are Pfizer Inc., GlaxoSmithKline PLC, Novartis AG, Merck & Co. Inc., AstraZeneca PLC, Roche Holding AG, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Bayer AG, Amgen Inc., Eli Lilly and Company, AbbVie Inc., Sanofi.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 5.8% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Endometrial Cancer include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Endometrial Cancer in 2023.
